Savana, a global medical company developing innovative Artificial Intelligence (AI) technologies to unlock the clinical value embedded in clinical data (like Electronic Medical Records and clinical trials), has closed a USD25 million funding round led by Conexo Ventures, along with Knuru Capital and Aldea Ventures.
Existing investors Seaya Ventures and Cathay Innovation also reinvested in the round.
Savana is a Madrid-based health tech startup using AI to provide medical knowledge based on “Real World Evidence” to enhance research and build predictive models to enhance patients’ lives.
